<DOC>
	<DOCNO>NCT01301573</DOCNO>
	<brief_summary>The purpose observational study long term follow-up Parkinson 's patient participate clinical trial receive AAV-GAD gene transfer subthalamic nucleus ( STN ) region brain . Patients follow year five ( 5 ) year . The study monitor evaluate long term effect AAV-GAD provide long term safety information .</brief_summary>
	<brief_title>Long Term Follow-Up Study rAAV-GAD Treated Subjects</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Participated clinical trial receive AAVGAD Able give inform consent participate study Received Deep Brain Stimulation receive AAVGAD Received experimental device brain receiving AAVGAD Had type brain surgery receive AAVGAD Received experimental therapy ( drug biologic ) Parkinson 's disease indication receive AAVGAD</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>